Zhende Medical Co., Ltd. (SHA:603301)
China flag China · Delayed Price · Currency is CNY
82.00
-1.00 (-1.20%)
Nov 17, 2026, 3:00 PM CST

Zhende Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
4,6324,3074,2474,1056,1314,907
Other Revenue
23.0523.0516.6721.66.47184.42
4,6554,3304,2644,1276,1385,092
Revenue Growth
7.68%1.54%3.32%-32.76%20.54%-51.04%
Cost of Revenue
3,0922,8992,8502,8504,0633,353
Gross Profit
1,5621,4311,4141,2772,0751,738
Selling, General & Admin
990.77926890.18894.44984.23808.32
Research & Development
145.18142.43135.49138.95227153.14
Other Operating Expenses
27.5523.222.928.1541.848.33
Operating Expenses
1,1771,1051,0391,0431,2621,011
Operating Income
385.35326.11375.05233.3812.89727.2
Interest Expense
-28.23-31.49-28.73-28.93-33.54-25.07
Interest & Investment Income
35.9825.9935.9246.7610.6152.4
Currency Exchange Gain (Loss)
-4.59-4.5924.311.7621.89-15.69
Other Non Operating Income (Expenses)
-20.16-4.11-2.87-1.98-1.03-2.07
EBT Excluding Unusual Items
368.35311.92403.68260.9810.81736.77
Impairment of Goodwill
----2.29-3.91-
Gain (Loss) on Sale of Investments
4.020.63-12.25-21.06-71.06-2.7
Gain (Loss) on Sale of Assets
-7.80.6493.43-15.96-13.53-0.61
Asset Writedown
-19.661.8-9.09-52.02-4.97-3.31
Other Unusual Items
9.849.84-0.3149.3484.3889.81
Pretax Income
354.75324.83475.46218.89801.72819.95
Income Tax Expense
54.8957.7378.255.4999.9699
Earnings From Continuing Operations
299.86267.1397.21213.4701.76720.95
Minority Interest in Earnings
-5.06-6.28-12.04-15-21.88-125.08
Net Income
294.8260.82385.17198.4679.88595.86
Net Income to Common
294.8260.82385.17198.4679.88595.86
Net Income Growth
4.95%-32.29%94.14%-70.82%14.10%-76.63%
Shares Outstanding (Basic)
261263266268237226
Shares Outstanding (Diluted)
261263266268237227
Shares Change
-1.90%-0.82%-0.92%13.18%4.56%11.08%
EPS (Basic)
1.130.991.450.742.872.64
EPS (Diluted)
1.130.991.450.742.872.63
EPS Growth
6.98%-31.72%95.95%-74.22%9.13%-78.96%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
132.47-11.73-308.55-147.13491.92122.16
Free Cash Flow Per Share
0.51-0.04-1.16-0.552.080.54
Dividend Per Share
0.3000.3000.6501.250-0.600
Dividend Growth
-53.85%-53.85%-48.00%---73.91%
Gross Margin
33.57%33.05%33.16%30.93%33.80%34.14%
Operating Margin
8.28%7.53%8.80%5.65%13.24%14.28%
Profit Margin
6.33%6.02%9.03%4.81%11.08%11.70%
Free Cash Flow Margin
2.85%-0.27%-7.24%-3.56%8.02%2.40%
EBITDA
704.29614.01621.58476.27998.26858.7
EBITDA Margin
15.13%14.18%14.58%11.54%16.27%16.86%
D&A For EBITDA
318.94287.9246.52242.97185.38131.51
EBIT
385.35326.11375.05233.3812.89727.2
EBIT Margin
8.28%7.53%8.80%5.65%13.24%14.28%
Effective Tax Rate
15.47%17.77%16.46%2.51%12.47%12.07%
Revenue as Reported
4,6554,3304,2644,1276,1385,092
Advertising Expenses
-21.2142.8338.1739.9420.1